A Study on the Occurrence and Prevention of Perioperative Stroke after Coronary Artery Bypass Grafting.

Abstract Cerebral infarction after coronary artery bypass grafting (CABG) is a serious complication and a problem that remains unsolved. We will report the onset of cerebral infarction in CABG patients in our institution, and its cause, preventive method. The subjects of this research were 761 patients who underwent on-pump isolated CABG. Preoperative, intraoperative and postoperative factors, onset of cerebral infarction and atrial fibrillation were investigated. Postoperative cerebral infarction and postoperative atrial fibrillation were recognized in 1.4% and 24% of the patients, respectively. The risk factors for cerebral infarction were carotid artery stenosis, cardiopulmonary bypass time g180 min, postoperative atrial fibrillation, and β-blocker non-use. The risk factors for postoperative atrial fibrillation were 75 or higher years of age, chronic kidney diseases, emergency surgery, cardiopulmonary bypass time g180 min, intraoperative carperitide non-use, intraoperative landiolol hydrochloride non-use, preoperative angiotensin II receptor blockers (ARB) non-use, preoperative calcium antagonist use, preoperative statin use, postoperative β-blocker non-use, and postoperative aldosterone blocker non-use. The results of this study showed that cerebral infarction occurs frequently in patients who have developed atrial fibrillation, and it was considered that perioperative cerebral infarction can be prevented by perioperative β-blocker, carperitide, anticoagulation therapy and adequate extracorporeal circulation. Since preoperative, intraoperative and postoperative drug use is closely involved in the risk factor for postoperative atrial fibrillation, it was considered possible that adequate perioperative drug therapy can prevent atrial fibrillation and onset of cerebral infarction. (This article is a secondary publication of J Jpn Coron Assoc 2014; 20: 91-7.).

[1]  M. Ezekowitz,et al.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. , 2014, Circulation.

[2]  K. Nakata,et al.  Results of low-dose carperitide infusion in high-risk patients undergoing coronary artery bypass grafting. , 2013, The Annals of thoracic surgery.

[3]  S. Yusuf,et al.  Effects of off-pump and on-pump coronary-artery bypass grafting at 1 year. , 2013, The New England journal of medicine.

[4]  Takeshi Kimura,et al.  Comparison of frequency of postoperative stroke in off-pump coronary artery bypass grafting versus on-pump coronary artery bypass grafting versus percutaneous coronary intervention. , 2012, The American journal of cardiology.

[5]  A. Hirayama,et al.  Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study. , 2012, The Journal of thoracic and cardiovascular surgery.

[6]  M. Rezvanfard,et al.  The effect of a high dose of atorvastatin on the occurrence of atrial fibrillation after coronary artery bypass grafting. , 2012, The Annals of thoracic surgery.

[7]  A. Hirayama,et al.  Results of low-dose human atrial natriuretic peptide infusion in nondialysis patients with chronic kidney disease undergoing coronary artery bypass grafting: the NU-HIT (Nihon University working group study of low-dose HANP Infusion Therapy during cardiac surgery) trial for CKD. , 2011, Journal of the American College of Cardiology.

[8]  Magnus Hedberg,et al.  Early and delayed stroke after coronary surgery - an analysis of risk factors and the impact on short- and long-term survival. , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[9]  T. Nakai,et al.  Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial. , 2011, The Journal of thoracic and cardiovascular surgery.

[10]  Seung‐Jung Park,et al.  Stroke risk after coronary artery bypass graft surgery and extent of cerebral artery atherosclerosis. , 2011, Journal of the American College of Cardiology.

[11]  E. Blackstone,et al.  Temporal onset, risk factors, and outcomes associated with stroke after coronary artery bypass grafting. , 2011, JAMA.

[12]  A. Hirayama,et al.  Continuous low-dose infusion of human atrial natriuretic peptide in patients with left ventricular dysfunction undergoing coronary artery bypass grafting: the NU-HIT (Nihon University working group study of low-dose Human ANP Infusion Therapy during cardiac surgery) for left ventricular dysfunction. , 2010, Journal of the American College of Cardiology.

[13]  Chun-Hsu Pan,et al.  Regulatory mechanisms of atrial fibrotic remodeling in atrial fibrillation , 2008, Cellular and Molecular Life Sciences.

[14]  Silvia G. Priori,et al.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European society of cardiology committee for PRAC , 2006 .

[15]  W. Baumgartner,et al.  Stroke after cardiac surgery: short- and long-term outcomes. , 2001, The Annals of thoracic surgery.